UBS Group’s Evo Acquisition Corp. Unit EVOJU Stock Holding History

UBS Group’s Portfolio EVOJU Stock Details EVOJU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-900	Closed	-$8.88K	–	10340
2023 Q1	$8.88K	Sell	900 -901	-50%	-$9.05K	﹤0.01%	7686
2022 Q4	$18.9K	Buy	1,801 +6	+0.3%	+$60	﹤0.01%	7707
2022 Q3	$18K	Sell	1,795 -353	-16%	-$3.48K	﹤0.01%	7563
2022 Q2	$21K	Buy	2,148 +1,000	+87%	+$9.85K	﹤0.01%	6846
2022 Q1	$11K	Buy	1,148 +892	+348%	+$8.83K	﹤0.01%	8354
2021 Q4	$3K	Buy	+256	New	+$2.55K	﹤0.01%	9740
2021 Q3	–	Sell	-756	Closed	-$8K	–	10390
2021 Q2	$8K	Buy	+756	New	+$7.55K	﹤0.01%	8277

UBS Group's EVOJU Position: Q2 2023 in Review

UBS Group sold out of Evo Acquisition Corp. Unit (EVOJU) in Q2 2023, closing a stake of 900 shares — an estimated $8.88K sold.

UBS Group first reported a position in EVOJU in Q2 2021 and held it in 7 quarters. The position peaked at $21K in Q2 2022. 0 funds tracked by Wall St. Rank hold EVOJU as of Q2 2023.

UBS Group reported no remaining Evo Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
UBS Group sold 900 Evo Acquisition Corp. Unit shares in Q2 2023, an estimated $8.88K.
UBS Group first reported a position in Evo Acquisition Corp. Unit in Q2 2021 and held it in 7 quarters.
UBS Group's Evo Acquisition Corp. Unit position peaked at $21K in Q2 2022.
0 funds tracked by Wall St. Rank held Evo Acquisition Corp. Unit as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.